INC.

Leading Proxy Advisory Firm ISS Recommends Illumina Shareholders Vote “FOR” Eight of Illumina’s Highly Qualified Director Nominees

by

SAN DIEGO, May 12, 2023 /PRNewswire/ — Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that Institutional Shareholder Services (“ISS”), a leading independent proxy voting and corporate governance advisory firm, recommends Illumina shareholders vote FOR Illumina CEO Francis deSouza and Board member Robert Epstein. Illumina’s Annual Meeting is scheduled … Read more

Rakuten Medical to Present New Data of Alluminox™ Treatment using ASP-1929 in Combination with anti-PD-1 at AHNS 2023

by

SAN DIEGO, May 12, 2023 /PRNewswire/ — Rakuten Medical, Inc. (Rakuten Medical), a global biotechnology company developing and commercializing precision, cell-targeting therapies based on its proprietary Alluminox™ platform, today announced that the abstract ‘Safety and efficacy findings from a phase 1b/2 open-label study of a novel combination of ASP-1929 photoimmunotherapy with anti-PD-1 therapy in EGFR-expressing advanced … Read more

Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2023 Financial Results and Provides Business Update

by

$29.1 million in cash and cash equivalents as of March 31, 2023; $15 million registered direct offering in May 2023 extends runway through May 2024 Halo-Lido Phase 2b trial completed with topline results anticipated by end of calendar Q2 2023 CRANFORD, N.J., May 12, 2023 /PRNewswire/ — Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: … Read more

Birchbox Assets Purchased from FemTec Health by Retention Brands

by

HOUSTON, May 12, 2023 /PRNewswire/ — Today, FemTec Health, Inc. announced the purchase of its Birchbox assets, effective April 12, 2023, by Retention Brands. Early this year as part of its strategic tightening around core healthcare businesses, FemTec Health engaged a national financial consulting firm to advise and explore possibilities for the sale of some of … Read more

Pulmatrix Announces First Quarter 2023 Financial Results and Provides Corporate Update

by

Patient dosing initiated for Phase 2b study of PUR1900 for ABPA Phase 1 study of PUR3100 for migraine achieves positive topline results $30.8 million in cash and cash equivalents at the end of Q1 2023 providing projected cash runway into Q4 2024 LEXINGTON, Mass., May 12, 2023 /PRNewswire/ — Pulmatrix, Inc. (NASDAQ: PULM), a clinical-stage biopharmaceutical company … Read more

ViewRay’s MRIdian® to be Featured at Leading European Radiation Oncology Meeting

by

50 clinical presentations and posters highlight benefits of MRI-guided radiation adaptive therapy DENVER, May 12, 2023 /PRNewswire/ — ViewRay, Inc. (Nasdaq: VRAY) announced today that the company’s MRIdian MRI-guided radiation therapy system will be featured at the Annual Meeting of the European Society for Radiotherapy and Oncology (ESTRO) with over 50 presentations and posters highlighting … Read more

Invivoscribe annonce l’approbation IVDR du test de mutation FLT3 LeukoStrat CDx

by

SAN DIEGO, 12 mai 2023 /PRNewswire/ — « Aujourd’hui, nous sommes heureux d’annoncer que le test de mutation FLT3 LeukoStrat® CDx d’Invivoscribe a été approuvé par BSI (Pays-Bas) et l’EMA en tant que test CDx de classe C, répondant aux nouvelles exigences rigoureuses de l’IVDR (règlement (UE) 2017/746). Invivoscribe est l’une des premières sociétés au monde à obtenir une approbation IVDR … Read more

Nippon Express Italia obtiene la certificación IATA CEIV Pharma

by

– Nippon Express Italia obtiene la certificación IATA CEIV Pharma para su instalación cerca del aeropuerto de Milán Malpensa TOKIO, 12 de mayo de 2023 /PRNewswire/ — Nippon Express Italia S.p.A. (en adelante, “NX Italia”), empresa del grupo NIPPON EXPRESS HOLDINGS, INC., ha adquirido la certificación IATA CEIV Pharma*, un certificado de calidad para el transporte … Read more

Nippon Express Italia erhält IATA-CEIV-Pharma-Zertifizierung für seine Anlage in der Nähe des Flughafens Mailand-Malpensa

by

TOKIO, 12. Mai 2023 /PRNewswire/ — Nippon Express Italia S.p.A. (im Folgenden „NX Italia”), ein Konzernunternehmen der Nippon Express Holdings, Inc., hat die IATA-CEIV-Pharma-Zertifizierung* erhalten, ein Qualitätszertifikat für pharmazeutische Transporte, das von der International Air Transport Association (IATA) eingerichtet wurde, für seine Lageranlage in Lainate, nahe des Flughafens Mailand-Malpensa, mit Wirkung vom 3. April dieses … Read more

Nippon Express Italia obtient la certification IATA CEIV Pharma pour ses installations près de l’aéroport de Milan Malpensa

by

TOKYO, 12 mai 2023 /PRNewswire/ — Nippon Express Italia S.p.A. (ci-après « NX Italia »), une société du groupe NIPPON EXPRESS HOLDINGS, INC, a obtenu la certification IATA CEIV Pharma*, un certificat de qualité pour le transport pharmaceutique établi par l’Association du transport aérien international (IATA), pour son entrepôt de Lainate, près de l’aéroport de Milan Malpensa, à compter du 3 avril de cette année. Logo : https://kyodonewsprwire.jp/img/202305095498-O1-I17xe4r6 … Read more